6586.TWO CHO Pharma Inc.

Healthcare Biotechnology Taiwan OTC Exchange
76.70 TWD
Close of Nov 5, 2026
22.75 148.50
Market cap
TWD 16.4B
P/E
-
P/B
8.14x
ROE
-11.8%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 6586.TWO undervalued?

Graham number

The Graham number of CHO Pharma Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

CHO Pharma Inc. fundamental analysis

No fundamental analysis for CHO Pharma Inc. yet.

CHO Pharma Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About CHO Pharma Inc.

CHO Pharma, Inc., engages in research and development of biotechnology in Taiwan. It develops glycoengineering platform technologies, including SAR-based glycoengineered biobetters; glycosite-specific antibody-drug conjugates (ADCs); novel antibodies and vaccines targeting novel carbohydrate antigens; and programs using its glycoengineering technologies. The company also provides CHOptimax, an in vitro enzymatic one-pot process that converts naked antibodies into glycoengine…

Full company profile